Locations:
Min Investment:
Max Investment:
Target Investment:
2021
Provide technical, organizational and strategic leadership for the growth and development of emerging biotechnology companies.
2000 - 2023
2000 - 2023
Dr. Baffi joined BioMarin in May 2000 and served as President of Global Manufacturing & Technical Operations responsible for overseeing the company’s manufacturing, process development, quality, engineering, logistics and analytical chemistry departments. From 1986 to 2000, Dr. Baffi served in a number of increasingly responsible positions at Genentech, primarily in the functional area of quality control. Prior to Genentech, Dr. Baffi worked for Cooper BioMedical as a Research Scientist and at Becton Dickinson Research Center as a Post-Doctoral Fellow. Dr. Baffi has contributed to more than 30 regulatory submissions for product approval in the United States and Europe and to more than 50 regulatory submissions for investigational new drug testing. Dr. Baffi received a Ph.D, M.Phil and a B.S. in biochemistry from the City University of New York and an M.B.A. from Regis University.
1986 - 2000
1986 - 2000
Director of Collaborations, 1998-2000 Director QC Clinical Development & Marketed Products, 1994-1998 Associate Director- QC Clinical Development, 1992-1993 Manager QC Marketed Products & Raw Materials, 1989-1991 Group Leader QC Stability, 1986-1988 Over a 14-year period held positions of enhanced leadership and responsibility within Quality. Developed key procedures, controls and strategies to support the approval process, launch or continuing supply of 16 commercial biotechnology products. Developed the strategies to manage all aspects of partnerships to ensure agreements, project plans, timelines and regulatory requirements were met.